Apidra News and Research

RSS
Retooled vaccine raises hopes as a lower-cost treatment for Type 1 diabetes

Retooled vaccine raises hopes as a lower-cost treatment for Type 1 diabetes

Adocia initiates phase IIa clinical trial of BioChaperone Lispro formulation

Adocia initiates phase IIa clinical trial of BioChaperone Lispro formulation

Sanofi-aventis releases Lantus(R) study results for type 2 diabetes

Sanofi-aventis releases Lantus(R) study results for type 2 diabetes

Halozyme second-quarter revenue increases to $3.2 million

Halozyme second-quarter revenue increases to $3.2 million

Lantus and Apidra improve outcomes, decrease glycemic variability: Study

Lantus and Apidra improve outcomes, decrease glycemic variability: Study

Lantus and Apidra injections improve glycemic control, reduce hospital complications: Study

Lantus and Apidra injections improve glycemic control, reduce hospital complications: Study

AgaMatrix, sanofi-aventis announce long-term partnership for BGM solutions

AgaMatrix, sanofi-aventis announce long-term partnership for BGM solutions

sanofi-aventis reports 2009 fourth-quarter and full-year net earnings

sanofi-aventis reports 2009 fourth-quarter and full-year net earnings

Children with type 1 diabetes benefit from rapid-acting insulin analogues; potential harm remains unclear

Children with type 1 diabetes benefit from rapid-acting insulin analogues; potential harm remains unclear

Health Canada approves new Lantus ClikSTAR reusable insulin pen

Health Canada approves new Lantus ClikSTAR reusable insulin pen

Saskatchewan government makes insulin detemir more accessible to residents

Saskatchewan government makes insulin detemir more accessible to residents

Rapid-acting insulin analogues in diabetes mellitus type 1

Rapid-acting insulin analogues in diabetes mellitus type 1

Short acting insulin analogues versus regular human insulin in patients with diabetes mellitus

Short acting insulin analogues versus regular human insulin in patients with diabetes mellitus

New and Generic Drug Approvals from FDA

New and Generic Drug Approvals from FDA